Description
PT-141, also known as Bremelanotide, is a modified cyclic peptide supplied for controlled laboratory, analytical, and scientific research.
Its molecular identity includes an N-terminal acetyl group, non-standard norleucine, D-phenylalanine, and a cyclic structure formed through an internal Asp-Lys lactam linkage. These structural features are essential for accurate analytical identification and distinguish PT-141 from conventional linear peptides.
For technical documentation, the exact salt or counter-ion form, purity specification, terminal state, and lot-specific analytical profile should be confirmed using the applicable Certificate of Analysis.
Research Applications
PT-141 may be examined in controlled non-clinical research involving:
- Modified peptide characterization
- Cyclic peptide analysis
- Structure-function research
- Ligand-receptor interaction studies
- Molecular signaling research
- Stereochemical characterization
- Chromatographic profiling
- Stability assessment
- Non-clinical biochemical and cellular models
Experimental observations should remain specific to the applicable research system and should not be interpreted as evidence of behavioral, reproductive, therapeutic, or clinical effectiveness.
Structural Information
PT-141 is commonly represented as:
Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH
Key structural characteristics include:
- Seven-residue peptide architecture
- N-terminal acetylation
- Norleucine residue
- D-phenylalanine residue
- Internal Asp-Lys lactam cyclization
- Free C-terminal carboxyl group
- Product-dependent counter-ion characteristics
Analytical Identification
Relevant analytical characterization may include:
- Peptide identity confirmation
- Molecular-mass assessment
- Cyclic structure verification
- Stereochemical characterization
- N-terminal acetylation confirmation
- Chromatographic purity testing
- Counter-ion assessment
- Lot-specific quality analysis
Specifications & Documentation
Lot-specific documentation should be reviewed for:
- PT-141 identity
- CAS number
- Molecular formula
- Molecular weight
- Complete peptide structure
- Cyclization state
- Stereochemical configuration
- Terminal modifications
- Salt or counter-ion form
- Purity specification
- Analytical testing
- Lot or batch information
- Certificate of Analysis
- Storage requirements
Authenticated product-specific documentation should take precedence over generalized reference values.
Storage & Handling
Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.
Follow established laboratory procedures appropriate for modified cyclic research peptides.
Research Use Only
PT-141 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.
Disclaimer
For research use only. Not for human or veterinary use. Not intended for consumption, administration, behavioral use, reproductive use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, behavioral, reproductive, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.





Reviews
There are no reviews yet.